![Study: Israeli-made anti-COVID nasal spray reduced infection at mass gathering | The Times of Israel Study: Israeli-made anti-COVID nasal spray reduced infection at mass gathering | The Times of Israel](https://static.timesofisrael.com/www/uploads/2021/02/taffixnose-1024x640.jpg)
Study: Israeli-made anti-COVID nasal spray reduced infection at mass gathering | The Times of Israel
![Study: Israeli-made anti-COVID nasal spray reduced infection at mass gathering | The Times of Israel Study: Israeli-made anti-COVID nasal spray reduced infection at mass gathering | The Times of Israel](https://static.timesofisrael.com/www/uploads/2021/02/taffix-640x400.jpg)
Study: Israeli-made anti-COVID nasal spray reduced infection at mass gathering | The Times of Israel
Taffix™ is a scientifically proven nasal spray that creates a hostile microenvironment in the nose where up to 97% of airborne viruses can't survive.... | By PAC3 - Facebook
Low pH Hypromellose (Ta x™) nasal powder spray reduced SARS-CoV-2 infection rate post mass- gathering event at a highly endemi
![PDF) TaffiX® nasal powder spray forms an effective barrier against infectious new variants of SARS-CoV-2 (COVID-19) PDF) TaffiX® nasal powder spray forms an effective barrier against infectious new variants of SARS-CoV-2 (COVID-19)](https://i1.rgstatic.net/publication/350913017_TaffiXR_nasal_powder_spray_forms_an_effective_barrier_against_infectious_new_variants_of_SARS-CoV-2_COVID-19/links/6079d28d2fb9097c0ceca0c8/largepreview.png)
PDF) TaffiX® nasal powder spray forms an effective barrier against infectious new variants of SARS-CoV-2 (COVID-19)
![Taffix® Nasal Powder Spray Forms an Effective Barrier Against Infectious New Variants of SARS-Cov-2 (Alpha, Beta and Delta) Taffix® Nasal Powder Spray Forms an Effective Barrier Against Infectious New Variants of SARS-Cov-2 (Alpha, Beta and Delta)](https://www.fortunejournals.com/fulltext-images/taffixreg-nasal-powder-spray-forms-03.png)
Taffix® Nasal Powder Spray Forms an Effective Barrier Against Infectious New Variants of SARS-Cov-2 (Alpha, Beta and Delta)
![Nasus Pharma Announces First Clinical Data Demonstrating Efficacy of Taffix™ Intranasal Antiviral Protection Against SARS-CoV-2 in Super Spread Event Nasus Pharma Announces First Clinical Data Demonstrating Efficacy of Taffix™ Intranasal Antiviral Protection Against SARS-CoV-2 in Super Spread Event](https://mma.prnewswire.com/media/1311013/Nasus_Pharma_Logo.jpg?p=facebook)
Nasus Pharma Announces First Clinical Data Demonstrating Efficacy of Taffix™ Intranasal Antiviral Protection Against SARS-CoV-2 in Super Spread Event
![Taffix® Nasal Powder Spray Forms an Effective Barrier Against Infectious New Variants of SARS-Cov-2 (Alpha, Beta and Delta) Taffix® Nasal Powder Spray Forms an Effective Barrier Against Infectious New Variants of SARS-Cov-2 (Alpha, Beta and Delta)](https://www.fortunejournals.com/fulltext-images/taffixreg-nasal-powder-spray-forms-02.png)
Taffix® Nasal Powder Spray Forms an Effective Barrier Against Infectious New Variants of SARS-Cov-2 (Alpha, Beta and Delta)
![Taffix nasal spray targets travel retail expansion as health products build channel presence : The Moodie Davitt Report -The Moodie Davitt Report Taffix nasal spray targets travel retail expansion as health products build channel presence : The Moodie Davitt Report -The Moodie Davitt Report](https://www.moodiedavittreport.com/wp-content/uploads/2021/07/TAFFIX-4-X-1000MG-1.png)